BioPharma Dive Feb 4, 2026 Lilly soars again as fast-selling weight loss drugs top Wall Street projections
BioPharma Dive Feb 4, 2026 Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan
BioPharma Dive Feb 2, 2026 Building a robust in-process testing plan for cell therapy manufacturing success
BioPharma Dive Jan 30, 2026 AstraZeneca leans into obesity, striking wide-ranging alliance with China’s CSPC
BioPharma Dive Jan 29, 2026 Sanofi expects vaccine sales growth to dip amid ‘challenging environment’
BioPharma Dive Jan 28, 2026 Lilly bets on Seamless, delving further into genetic medicine for hearing loss
BioPharma Dive Jan 28, 2026 Drugs for cancer, arthritis and HIV on Medicare’s list for 2028 price cuts